Aparna Biosciences Overview

  • Founded
  • 2007

Founded
  • Status
  • Out of Business

  • Employees
  • 4

Employees
  • Latest Deal Type
  • Out of Business

Aparna Biosciences General Information

Description

Developer of biomedical nanoparticle technology and products for research and treatment of human disease. The company develops tissue targeting technology platforms that can advance biomedical research and ultimately revolutionary therapeutics.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 12111 Parklawn Drive
  • Suite 123
  • Rockville, MD 20852
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aparna Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Oct-2017 Completed Out of Business
2. Accelerator/Incubator 10-Aug-2011 Completed Startup
1. Grant 01-Sep-2009 $1.44M Completed Startup
To view Aparna Biosciences’s complete valuation and funding history, request access »

Aparna Biosciences Patents

Aparna Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2257280-A1 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use Withdrawn 26-Feb-2008 00000000
US-20110312877-A1 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use Abandoned 26-Feb-2008 00000000 0
EP-2257280-A4 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use Withdrawn 26-Feb-2008 00000000 0
US-9095568-B2 Therapeutic and vaccine polyelectrolyte nanoparticle compositions Expired - Fee Related 26-Sep-2007 0000000000 0
EP-2197457-A4 Therapeutic and vaccine polyelectrolyte nanoparticle compositions Withdrawn 26-Sep-2007 A61K31/575 0
To view Aparna Biosciences’s complete patent history, request access »

Aparna Biosciences Executive Team (2)

Name Title Board Seat Contact Info
Martin Woodle Ph.D Co-Founder & Chief Executive and Scientific Officer
Puthupparampil Scaria Ph.D Co-Founder & Vice President, Research & Development
To view Aparna Biosciences’s complete executive team members history, request access »

Aparna Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial